Skip to main content
SpringerLink
Log in

Boerhaavia diffusa Extract Acts as a Specific Antituberculosis Agent in Vitro Against Mycobacterium tuberculosis H37Rv Infection

  • BIOCHEMISTRY, BIOPHYSICS, AND MOLECULAR BIOLOGY
  • Published:
Doklady Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

The present study investigated Boerhaavia diffusa extract against Mycobacterium tuberculosis H37Rv (M.tb) infection in vitro and explored the underlying mechanism. The study demonstrated that Boerhaavia diffusa extract significantly (p < 0.05) reduced RAW 264.7 and A549 cell viability in concentration dependent manner. In BEAS-2B, NuLi-1 cells and splenocytes no significant (p > 0.05) reduction in viability was observed on treatment with 2.5 to 20 mg/L concentrations of Boerhaavia diffusa. The M. tb‑induced increase in TNF‑α expression was significantly (p < 0.05) reversed by Boerhaavia diffusa treatment in RAW 264.7 and BEAS-2B cells. Moreover, Boerhaavia diffusa treatment significantly (p < 0.05) inhibited M.tb‑induced increase in IL-6 and IL‑1β expression in RAW 264.7 and BEAS-2B cells. Boerhaavia diffusa treatment of RAW 264.7 and BEAS-2B cells significantly (p < 0.05) reversed M.tb‑induced increase in iNOS and COX‑2 expression. Additionally, in Boerhaavia diffusa treated cells M.tb‑induced increase in NO release was significantly (p < 0.05) reduced compared to untreated cells. In summary, Boerhaavia diffusa treatment inhibits pro-inflammatory cytokine production, NO release and regulate immunomodulatory mediators in M.tb‑infected RAW 264.7 and BEAS-2B cells. Therefore, Boerhaavia diffusa may be developed as a therapeutic agent for treatment of M.tb‑infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.
Fig. 6.

Similar content being viewed by others

REFERENCES

  1. Ahmad, Z., Makaya, H.N., and Grosset, J.H., History of TB drug discovery: early evaluation studies and lessons learnt from them. Antituberculosis chemotherapy, Prog. Respir. Res., 2011, vol. 40, pp. 1–8.

    Google Scholar 

  2. WHO Global tuberculosis report, 2016. http://reliefweb.int/sites/reliefweb.int/files/resources/gtbr2016_main_text.pdf.

  3. Lalloo, U.G., Pillay, S., Mngqibisa, R., et al., HIV and COPD: a conspiracy of risks, Respirology, 2016, vol. 21, pp. 1166–1172.

    Article  Google Scholar 

  4. Lechartier, B., Rybniker, J., Zumla, A., et al., Tuberculosis drug discovery in the post genomic era, EMBO Mol. Med., 2014, vol. 6, pp. 158–168.

    Article  CAS  Google Scholar 

  5. Coussens, L.M. and Werb, Z., Inflammation and cancer, Nature, 2002, vol. 420, pp. 860–867.

    Article  CAS  Google Scholar 

  6. Lee Y.J., Han, S.B., Nam, S.Y., Oh, K.W., and Hong, J.T., Inflammation and Alzheimer’s disease, Arch. Pharm. Res., 2010, vol. 33, pp. 1539–1556.

    Article  CAS  Google Scholar 

  7. Achoui, M., Appleton, D., Abdulla, M.A., Awang, K., Mohd, M.A., and Mustafa, M.R., In vitro and in vivo anti-inflammatory activity of 17-O acetylacuminolide through the inhibition of cytokines, NF-kB translocation and IKKβ activity, PLoS One, 2010, vol. 5, e15105.

    Article  Google Scholar 

  8. Zumla, A., Rao, M., Parida, S.K., Keshavjee, S., Cassell, G., Wallis, R., Axelsson-Robertsson, R., Do-herty, M., and Maeurer, M., Inflammation and tuberculosis: host-directed therapies, J. Intern. Med., 2014, vol. 277, pp. 373–387.

    Google Scholar 

  9. Roy, S., Sharma, S., Sharma, M., Aggarwal, R., and Bose, M., Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to mycobacterium tuberculosis, Immunology, 2004, vol. 112, pp. 471–480.

  10. Rajpoot, K. and Mishra, R.N., Boerhaavia diffusa roots (Punarnava mool)—review as rasayan (rejuvenator/antiaging), Int. J. Res. Pharm. Biomed. Sci., 2011, vol. 2, pp. 1451–1460.

  11. Nalamolu, R.K., Boini, K.M., and Nammi, S., Effect of chronic administration of Boerhaavia diffusa Linn. leaf extract on experimental diabetes in rats, Trop. J. Pharm. Res., 2004, vol. 3, pp. 305–309.

    Google Scholar 

  12. Bhalla, T.N., Gupta, M.B., Sheth, P.K., and Bharga-va, K.P., Anti-inflammatory activity of Boerhaavia diffusa, Indian J. Physiol. Pharmacol., 1968, vol. 12, p. 37.

    Google Scholar 

  13. Medzhitov, R., Origin and physiological roles of inflammation, Nature, 2008, vol. 454, pp. 428–435.

  14. Subbian, S., Tsenova, L., O’Brien, P., Yang, G., Koo, M.S., Peixoto, B., Fallows, D., Dartois, V., Muller, G., and Kaplan, G., Phosphodiesterase 4 inhibition alters gene expression and improves isoniazid mediated clearance of mycobacterium tuberculosis in rabbit lungs, PLoS Pathog., 2011, vol. 7, p. e. 1002262.

    Article  Google Scholar 

  15. Bermudez, L.E. and Goodman, J., Mycobacterium tuberculosis invades and replicates within type ii alveolar cells, Infect. Immunol., 1996, vol. 64, pp. 1400–1406.

    Article  CAS  Google Scholar 

  16. Moita, E., Gil-Izquierdo, A., Sousa, C., Ferreres, F., Silva, L.R., Valentão, P., Domínguez-Perles, R., Baenas, N., and Andrade, P.B., Integrated analysis of COX-2 and iNOS derived inflammatory mediators in LPS-stimulated RAW macrophages pre-exposed to Echium plantagineum L. bee pollen extract, PLoS One, 2013, vol. 8, p. e. 59131.

    Article  Google Scholar 

  17. Weinberg, J.B., Nitric oxide synthase 2 and cyclooxygenase 2 interactions in inflammation, Immunol. Res., 2000, vol. 22, pp. 319–341.

    Article  CAS  Google Scholar 

  18. Roy, S., Sharma, S., Sharma, M., Aggarwal, R., and Bose, M., Induction of nitric oxide release from the human alveolar epithelial cell line A549: an in vitro correlate of innate immune response to Mycobacterium tuberculosis, Immunology, 2004, vol. 112, pp. 471–480.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Serosal Tuberculosis, Xi’an Chest Hospital, Xi’an, China

    Qinfang Zheng

  2. Department of Surgery, Xi’an Chest Hospital, Xi’an, China

    Hangkong Ren

  3. Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

    Shuanying Yang

Authors
  1. Qinfang Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hangkong Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shuanying Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shuanying Yang.

Ethics declarations

The authors declare that they have no conflict of interest.

COMPLIANCE WITH ETHICAL STANDARDS

The study was approved by Animal Ethics Committee, Second Affiliated Hospital of Xi’an Jiaotong University. All the experiments were performed in accordance with the guidelines issued by the United States National Institutes of Health.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zheng, Q., Ren, H. & Yang, S. Boerhaavia diffusa Extract Acts as a Specific Antituberculosis Agent in Vitro Against Mycobacterium tuberculosis H37Rv Infection. Dokl Biochem Biophys 499, 266–272 (2021). https://doi.org/10.1134/S160767292104013X

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S160767292104013X

Keywords:

Search

Navigation